Clinical Trials Directory

Trials / Completed

CompletedNCT06604377

Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features

Status
Completed
Phase
Study type
Observational
Enrollment
203 (actual)
Sponsor
Ruijin Hospital · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the predictive value of preoperative 18F-PSMA-1007 PET/MR in the predictive effect of biological recurrence (BCR) after radical prostatectomy (RP) for localized prostate cancer (PCa).

Detailed description

Construct a predictive model for biochemical recurrence (BCR) in patients after radical prostatectomy using imaging parameters from preoperative 18F-PSMA-1007 PET/MRI, and compare the predictive performance of this model with existing clinical models. Data from three centers will be collected, with datasets from two centers used as the training set for the selection of predictive factors and model construction, while the dataset from the remaining center will serve as the validation set to assess the predictive performance of the model for BCR after prostatectomy.

Conditions

Interventions

TypeNameDescription
OTHERObserveRuijin

Timeline

Start date
2023-11-01
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06604377. Inclusion in this directory is not an endorsement.